Table 2.

Inclusion and exclusion of diagnostic indicators at each Delphi round for lung cancer

Diagnostic indicatorRound 1 (mean score for importance)Round 2 (mean rank score)Round 3 (crucial)
Key risk factor
Smoking statusa5.001.13Y
Occupational exposurea4.544.50Y
Agea4.333.31Y
Second attendance with the same symptoma4.258.25Y
History of chronic obstructive pulmonary diseasea4.136.81Y
Second-hand smoke exposurea4.047.00Y
Socioeconomic status3.717.19Nb
Family history (first-degree relative)a3.589.56Y
Last consultation with a GP >6 months ago3.4612.88b
History of idiopathic pulmonary fibrosis3.4212.75b
History of tuberculosis3.3313.81b
Sex3.2511.19b
Alcohol intake3.1711.75b
Ethnicityb2.79b
Last consultation with a GP >5 years agoc10.38Nb
Patient thinks they may have lung cancera,c11.13Y
Patient attends with an adult family memberc15.75b
Localisation of painc12.63b
Reduced exercise tolerancea,cY
Symptom
Haemoptysisa4.961.25Y
Unintentional loss of weight reported by patienta4.794.44Y
Symptom durationa,d4.256.19Y
Cougha4.173.00Y
Hoarsenessa4.136.06Y
Dyspnoeaa4.004.38Y
Chest paina3.796.69Y
Bone pain3.929.88b
Loss of appetite3.887.88b
Back pain3.8810.56b
Fatigue3.888.81b
Shoulder pain3.758.88b
Sign
Cachexiaa4.713.94Y
Pleural massa4.67
Pleural effusiona4.673.69Y
Superior vena cava obstructiona4.583.31Y
Objective weight lossa4.544.5Y
Lymphadenopathya4.255.94Y
Stridora4.216.00Y
Finger clubbing4.007.31b
Horner's syndromea,c6.50Y
Test
Abnormal chest X-raya4.791.06Y
Abnormal sputum cytology4.133.75Nb
Anaemia3.713.69Nb
Raised erythrocyte sedimentation rate3.754.63b
Raised C-reactive protein3.55.56b
Abnormal spirometry3.336.06b
Thrombocytosis3.257.31b
Hypercalcaemiac6.81b
Disturbed liver function testsc6.13b
  • a Included in round 3.

  • b Excluded in round 2.

  • c Added by participants in round 1.

  • d Refers to whether the symptom was present for a long period of time as opposed to only a short period.